Use of diethylcarbamazine to enhance antigen-antibody and antigen-host immune cell interactions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 13, 1990
Grant Date -
N/A
app pub date -
Nov 13, 1987
filing date -
Nov 13, 1987
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
This invention relates to the use of diethylcarbamazine (DEC), its analogs, homologs, and pharmaceutically acceptable salts thereof as an antiviral agent. This invention further relates to the use of DEC in in vivo diagnosis to increase antibodies to a particular disease; to the use of DEC in in vitro serologic assays to increase efficacy; and to the use of DEC as a vaccine adjuvant.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully